Latest & greatest articles for amoxicillin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on amoxicillin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on amoxicillin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for amoxicillin

21. Amoxicillin for Severe Acute Malnutrition in Children. (Full text)

Amoxicillin for Severe Acute Malnutrition in Children. 27410939 2016 07 15 2018 12 02 1533-4406 375 2 2016 07 14 The New England journal of medicine N. Engl. J. Med. Amoxicillin for Severe Acute Malnutrition in Children. 190-1 10.1056/NEJMc1605388 Rawson Timothy M TM Imperial College London, London, United Kingdom tmr07@ic.ac.uk. Moore Luke S LS Imperial College London, London, United Kingdom tmr07@ic.ac.uk. Holmes Alison H AH Imperial College London, London, United Kingdom tmr07@ic.ac.uk. eng (...) II-LA-0214-20008 Department of Health United Kingdom Letter Comment United States N Engl J Med 0255562 0028-4793 0 Anti-Bacterial Agents 804826J2HU Amoxicillin AIM IM N Engl J Med. 2016 Feb 4;374(5):444-53 26840134 N Engl J Med. 2016 Jul 14;375(2):191-2 27410938 Amoxicillin therapeutic use Anti-Bacterial Agents therapeutic use Female Humans Male Severe Acute Malnutrition drug therapy 2016 7 14 6 0 2016 7 14 6 0 2016 7 16 6 0 ppublish 27410939 10.1056/NEJMc1605388 10.1056/NEJMc1605388#SA1

2016 NEJM PubMed abstract

22. Amoxicillin for Severe Acute Malnutrition in Children. (Full text)

Amoxicillin for Severe Acute Malnutrition in Children. 27410940 2016 07 15 2018 12 02 1533-4406 375 2 2016 07 14 The New England journal of medicine N. Engl. J. Med. Amoxicillin for Severe Acute Malnutrition in Children. 191 10.1056/NEJMc1605388 Trehan Indi I Washington University in St. Louis, St. Louis, MO indi@alum.berkeley.edu. Schechtman Kenneth B KB Washington University in St. Louis, St. Louis, MO indi@alum.berkeley.edu. Manary Mark J MJ Washington University in St. Louis, St. Louis, MO (...) indi@alum.berkeley.edu. eng Letter Comment United States N Engl J Med 0255562 0028-4793 0 Anti-Bacterial Agents 804826J2HU Amoxicillin AIM IM N Engl J Med. 2016 Feb 4;374(5):444-53 26840134 N Engl J Med. 2016 Jul 14;375(2):191-2 27410938 Amoxicillin therapeutic use Anti-Bacterial Agents therapeutic use Female Humans Male Severe Acute Malnutrition drug therapy 2016 7 14 6 0 2016 7 14 6 0 2016 7 16 6 0 ppublish 27410940 10.1056/NEJMc1605388 10.1056/NEJMc1605388#SA2

2016 NEJM PubMed abstract

23. Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy (Abstract)

Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy To evaluate the efficacy and tolerability of replacing tetracycline with amoxicillin in bismuth quadruple therapy.Subjects who were infected with Helicobacter pylori and naïve to treatment were randomly (1:1) assigned to receive a 14-day modified bismuth quadruple therapy: lansoprazole 30 mg, amoxicillin 1 g, bismuth potassium citrate 220 mg (elemental bismuth), twice a day (...) % CI 90.5% to 99.3%) by per-protocol and 88.9% (95% CI 83.0% to 94.8%) and 88.8% (95% CI 82.8% to 94.8%) by intention-to-treat, respectively. Amoxicillin, metronidazole and clarithromycin resistance rates were 1.5%, 45.5% and 26.5%, respectively. Only clarithromycin resistance reduced treatment success (e.g., susceptible 98.6%, resistant 76.9%, p=0.001). Adverse events were more common in the metronidazole group.These results suggest that amoxicillin can substitute for tetracycline in modified 14

2015 EvidenceUpdates Controlled trial quality: uncertain

24. Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial. (Full text)

Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial. WHO recommends referral to hospital for possible serious bacterial infection in young infants aged 0-59 days. We aimed to assess whether oral amoxicillin treatment for fast breathing, in the absence of other signs, is as efficacious as the combination of injectable procaine (...) amoxicillin treatment twice per day for 7 days. A person who was off-site generated randomisation lists using computer software. Trained health professionals gave injections, but outcome assessors were masked to group allocations. The primary outcome was treatment failure by day 8 after enrolment, defined as clinical deterioration, development of a serious adverse event including death, persistence of fast breathing on day 4, or recurrence up to day 8. The primary analysis was per protocol and we used

2015 Lancet Controlled trial quality: predicted high PubMed abstract

25. Adverse effects of amoxicillin for any indication

Adverse effects of amoxicillin for any indication Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect

2015 PROSPERO

26. Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication (Full text)

Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication When prescribing antibiotics for common indications, clinicians need information about both harms and benefits, information that is currently available only from observational studies. We quantified the common harms of the most frequently prescribed antibiotic, amoxicillin, from randomized placebo-controlled trials.For this systematic review, we searched MEDLINE (...) , Embase and the Cochrane Central Register of Controlled Trials, without language restriction, for any randomized, participant-blinded, placebo-controlled trials of amoxicillin or amoxicillin-clavulanic acid for any indication, in any setting. Our main outcome was any reported adverse event.Of 730 studies identified, we included 45 trials: 27 involving amoxicillin, 17 involving amoxicillin-clavulanic acid and 1 involving both. The indications for antibiotic therapy were variable. The risk of bias

2014 EvidenceUpdates PubMed abstract

27. Maternal use of amoxicillin and risk of cleft lip and palate in infants: a systematic review

Maternal use of amoxicillin and risk of cleft lip and palate in infants: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2014 PROSPERO

28. Amoxicillin

Amoxicillin USE OF AMOXICILLIN IN PREGNANCY 0344 892 0909 USE OF AMOXICILLIN IN PREGNANCY (Date of issue: September 2014 , Version: 2.1 ) This is a UKTIS monograph for use by health care professionals. For case-specific advice please contact UKTIS on 0344 892 0909. To report an exposure please download and complete a . Please encourage all women to complete an . A corresponding patient information leaflet on is available at . Summary Amoxicillin is a broad spectrum β-lactam antibiotic used (...) in the treatment of susceptible bacterial infections, principally respiratory, middle ear and urinary tract infections. There are over 25,000 published cases of amoxicillin use during pregnancy, subsets of which have been analysed for various outcomes. No increased risks of spontaneous abortion, overall congenital malformation, intrauterine death, or neonatal complications were identified in these analyses. Two studies found a significant increase in cleft lip/palate, however this was not replicated

2014 UK Teratology Information Service

29. Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. (Full text)

Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. Acute otitis media (AOM) is a common problem in children, for which amoxicillin, with or without clavulanate, is frequently prescribed as a treatment of choice. The conventional recommendation is either three or four daily doses. However, nowadays it is frequently prescribed as once or twice daily doses. If once or twice daily amoxicillin, with or without clavulanate (...) , is as effective for acute otitis media as three or four times a day, it may be more convenient to give the medication once or twice a day to children and hence improve compliance.To compare the effectiveness of one or two daily doses with three or four daily doses of amoxicillin, with or without clavulanate, for the treatment of AOM in children; and to compare complication rates and adverse reactions.We searched CENTRAL 2013, Issue 2, MEDLINE (January 1950 to March week 1, 2013), EMBASE (1974 to March 2013

2013 Cochrane PubMed abstract

30. Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive

Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Full-mouth scaling and root planing (FMSRP) in combination with amoxicillin (AMX)/metronidazole (MET) (FMSRP + AMX/MET) therapy is more effective in treating generalized aggressive periodontitis (GAgP) than is FMSRP alone. Critical Summary Assessment

2013 ADA Center for Evidence-Based Dentistry

31. Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic

Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Preliminary evidence suggests scaling and root planing (SRP) in combination with amoxicillin (AMX)/metronidazole (MET) (SRP + AMX/MET) therapy may be more effective in treating chronic periodontitis (CP) than is SRP alone. Critical Summary Assessment

2013 ADA Center for Evidence-Based Dentistry

32. Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive

Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Full-mouth scaling and root planing (FMSRP) in combination with amoxicillin (AMX)/metronidazole (MET) (FMSRP + AMX/MET) therapy is more effective in treating generalized aggressive periodontitis (GAgP) than is FMSRP alone. Critical Summary Assessment

2013 ADA Center for Evidence-Based Dentistry

33. Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic

Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Preliminary evidence suggests scaling and root planing (SRP) in combination with amoxicillin (AMX)/metronidazole (MET) (SRP + AMX/MET) therapy may be more effective in treating chronic periodontitis (CP) than is SRP alone. Critical Summary Assessment

2013 ADA Center for Evidence-Based Dentistry

34. Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive

Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Aggressive L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Full-mouth scaling and root planing (FMSRP) in combination with amoxicillin (AMX)/metronidazole (MET) (FMSRP + AMX/MET) therapy is more effective in treating generalized aggressive periodontitis (GAgP) than is FMSRP alone. Critical Summary Assessment

2013 ADA Center for Evidence-Based Dentistry

35. Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic

Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis: Chronic L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Preliminary evidence suggests scaling and root planing (SRP) in combination with amoxicillin (AMX)/metronidazole (MET) (SRP + AMX/MET) therapy may be more effective in treating chronic periodontitis (CP) than is SRP alone. Critical Summary Assessment

2013 ADA Center for Evidence-Based Dentistry

36. ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD. (Full text)

ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD. 23552686 2013 05 13 2013 04 04 1539-3704 158 6 2013 Mar 19 Annals of internal medicine Ann. Intern. Med. ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD. JC3 10.7326/0003-4819-158-6-201303190-02003 Adams Sandra G SG University of Texas Health Science Center at San Antonio and South Texas Veterans

2013 Annals of Internal Medicine Controlled trial quality: uncertain PubMed abstract

37. Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy--EORTC Infectiou (Abstract)

Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy--EORTC Infectiou This double-blind, multicenter trial compared the efficacy and safety of a single daily oral dose of moxifloxacin with oral combination therapy in low-risk febrile neutropenic patients with cancer.Inclusion criteria were cancer, febrile (...) neutropenia, low risk of complications as predicted by a Multinational Association for Supportive Care in Cancer (MASCC) score > 20, ability to swallow, and ≤ one single intravenous dose of empiric antibiotic therapy before study drug treatment initiation. Early discharge was encouraged when a set of predefined criteria was met. Patients received either moxifloxacin (400 mg once daily) monotherapy or oral ciprofloxacin (750 mg twice daily) plus amoxicillin/clavulanic acid (1,000 mg twice daily). The trial

2013 EvidenceUpdates Controlled trial quality: predicted high

38. Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures

Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Systematic antimicrobial therapy using a combination of amoxicillin and metronidazole as an adjunct to scaling and root planing (SRP) can enhance the clinical benefits of non-surgical periodontal therapy in otherwise healthy teens and adults. Critical Summary

2013 ADA Center for Evidence-Based Dentistry

39. Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures

Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Systematic antimicrobial therapy using a combination of amoxicillin and metronidazole as an adjunct to scaling and root planing (SRP) can enhance the clinical benefits of non-surgical periodontal therapy in otherwise healthy teens and adults. Critical Summary

2013 ADA Center for Evidence-Based Dentistry

40. Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures

Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Investing (...) boards Evidence Education * Associated Topics Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Systematic antimicrobial therapy using a combination of amoxicillin and metronidazole as an adjunct to scaling and root planing (SRP) can enhance the clinical benefits of non-surgical periodontal therapy in otherwise healthy teens and adults. Critical Summary

2013 ADA Center for Evidence-Based Dentistry